Co-Targeting of DTYMK and PARP1 as a Potential Therapeutic Approach in Uveal Melanoma.
Oziębło S, Mizera J, Górska A, Krzyziński M, Karpiński P, Markiewicz A, Sąsiadek MM, Romanowska-Dixon B, Biecek P, Hoang MP, Mazur AJ, Donizy P.
Oziębło S, et al. Among authors: krzyzinski m.
Cells. 2024 Aug 14;13(16):1348. doi: 10.3390/cells13161348.
Cells. 2024.
PMID: 39195238
Free PMC article.